Dr. Micha Abeles
Board certified in internal medicine and rheumatology and a former professor of medicine at the University of Connecticut (UConn) Health Center, Dr. Micha Abeles established his reputation as a groundbreaking researcher over almost four decades. Alongside participating in numerous clinical trials leading the launch of medications such as Humira and Enbrel, Dr. Micha Abeles demonstrated the effectiveness of phosphodiesterase type 5 inhibitors in treating Buerger disease and methotrexate in treating rheumatoid arthritis. He was also amongst the authors on papers first describing eosinophilic fasciitis and fibromyalgia.
After receiving his BA from Cornell University, where he was an all-Ivy League fencer, Dr. Micha Abeles earned his MD from the State University of New York at Buffalo School of Medicine and Biomedical Sciences, where he also fulfilled his internship and residency. While attending SUNY Buffalo, he coached the school’s fencing team.
After completing his residency and internships, Dr. Micha Abeles functioned as the chief of the Outpatient Department and Special Clinics and director of the Rheumatology Clinic while stationed at Fort Monroe in Virginia. During his military service, he received a commendation for excellence in clinical skills and raising morale by organizing events and competitions.
In 1976, Dr. Micha Abeles left the U.S. Army to complete a fellowship in rheumatology at UConn, where he served in various capacities including being the chief of rheumatology. Between 1980 and 2016, Dr. Micha Abeles operated a part-time private medical practice, before operating on a full-time basis as of 2016.
Today, Dr. Micha Abeles continues his private practice in Meriden, Connecticut!